Novalis Biotech Acceleration fund
Investor profile
Venture capital
Novalis Biotech Acceleration fund has backed 3 European tech companies across 3 funding rounds between 2021 and 2022, joining rounds totalling €6.5M. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: Novalis Biotech Acceleration
Deals
3
distinct rounds
Companies
3
backed
Active span
2021–2022
2 yrs
Total round €
€6.5M
sum of rounds joined
Deals by year
distinct rounds / yearNovalis Biotech Acceleration fund — deals by year — interactive chart.
Data table
| Novalis Biotech Acceleration fund — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
Top sectors
by dealsNovalis Biotech Acceleration fund — top sectors — interactive chart.
Data table
| Novalis Biotech Acceleration fund — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsNovalis Biotech Acceleration fund — stages — interactive chart.
Data table
| Novalis Biotech Acceleration fund — stages | |
|---|---|
| Other | 2 |
| Series A | 1 |
Countries
by dealsNovalis Biotech Acceleration fund — countries — interactive chart.
Data table
| Novalis Biotech Acceleration fund — countries | |
|---|---|
| Belgium | 1 |
| France | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Trince | Belgium | 1 | €4.0M |
| Carroucell | France | 1 | €1.5M |
| Alithea Genomics | Switzerland | 1 | €1.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Trince | Other | €4.0M | 2021-12 |
| Carroucell | Series A | €1.5M | 2022-09 |
| Alithea Genomics | Other | €1.0M | 2022-05 |